Novel formulations for topical delivery of tranexamic acid: assessing the need of epidermal targeting for hyperpigmentation disorders

References

• Nicolaidou E, Katsambas AD. Pigmentation disorders: hyperpigmentation and hypopigmentation. Clin Dermatol. 2014;32(1):66–72.
   PubMed Web of Science ®Google Scholar
• Plensdorf S, Martinez J. Common pigmentation disorders. Am Fam Physician. 2009;79(2):109–116.
   PubMed Web of Science ®Google Scholar
• Taylor A, Pawaskar M, Taylor SL, et al. Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study. J Cosmet Dermatol. 2008;7(3):164–168. DOI:10.1111/j.1473-2165.2008.00384.x
   PubMedGoogle Scholar
• Sanchez JL, Vazquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol. 1982;21(1):55–59.
   PubMed Web of Science ®Google Scholar
• Fabi SG, Goldman MP. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging. J Drugs Dermatol. 2013 Mar;12(3):S32–7—.
   PubMed Web of Science ®Google Scholar
• Lajis AFB, Hamid M, Ariff AB. Depigmenting effect of kojic acid esters in hyperpigmented B16F1 melanoma cells. J Biomed Biotechnol. 2012;2012:952452. Mehta K, editor. DOI:10.1155/2012/952452
   PubMedGoogle Scholar
• Deo KS, Dash KN, Sharma YK, et al. Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety. Indian J Dermatol. 2013 Jul;58(4):281–285.
   PubMedGoogle Scholar
• Ortonne JP. Retinoid therapy of pigmentary disorders. Dermatol Ther. 2006;19(5):280–288.
   PubMed Web of Science ®Google Scholar
• Kakita LS, Lowe NJ. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. Clin Ther. 1998;20(5):960–970.
   PubMed Web of Science ®Google Scholar
• Lim Y-J, Lee EH, Kang TH, et al. Inhibitory effects of arbutin on melanin biosynthesis of α-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues. Arch Pharm Res. 2009;32(3):367–373. DOI:10.1007/s12272-009-1309-8
   PubMed Web of Science ®Google Scholar
• Bissett DL, Miyamoto K, Sun P, et al. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26(5):231–238. DOI:10.1111/j.1467-2494.2004.00228.x
   PubMedGoogle Scholar
• González-Molina V, Martí-Pineda A, González N. Topical treatments for melasma and their mechanism of action. J Clin Aesthet Dermatol. 2022;15(5):19–28.
   PubMedGoogle Scholar
• Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20(5):308–313.
   PubMed Web of Science ®Google Scholar
• Bruce S. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months. J Drugs Dermatol. 2013 Mar;12(3):S27–31—.
   PubMed Web of Science ®Google Scholar
• Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of the antifibrinolytic action plasminogen. Biochim Biophys Acta. 1981;673:75–85.
   PubMed Web of Science ®Google Scholar
• Molapour Rashedi S, Khajavi R, Rashidi A, et al. Nanocomposite-coated sterile cotton gas based on polylactic acid and nanoparticles (zinc oxide and copper oxide) and tranexamic acid drug with the aim of wound dressing. Regen Eng Transl Med. 2021;7(2):200–217. DOI:10.1007/s40883-021-00203-4
   Web of Science ®Google Scholar
• Liu Y, Han Y, Zhu T, et al. Targeting delivery and minimizing epidermal diffusion of tranexamic acid by hyaluronic acid-coated liposome nanogels for topical hyperpigmentation treatment. Drug Deliv. 2021;28(1):2100–2107. DOI:10.1080/10717544.2021.1983081
   PubMed Web of Science ®Google Scholar
• Lee J, Park J, Lim S. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg. 2006;32(5):626–631.
   PubMed Web of Science ®Google Scholar
• Wu S, Shi H, Wu H, et al. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg. 2012;36(4):964–970. DOI:10.1007/s00266-012-9899-9
   PubMed Web of Science ®Google Scholar
• Lee HC, Thng TGS, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75(2):385–392. Internet. DOI:10.1016/j.jaad.2016.03.001
   PubMed Web of Science ®Google Scholar
• Sharma R, Mahajan VK, Mehta KS, et al. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol. 2017;42(7):728–734. DOI:10.1111/ced.13164
   PubMed Web of Science ®Google Scholar
• Vijayakumar A, Baskaran R, Yoo BK. Skin permeation and retention of topical bead formulation containing tranexamic acid. J Cosmet Laser Ther. 2017 Jan 2;19(1):68–74. DOI:10.1080/14764172.2016.1247965
   PubMed Web of Science ®Google Scholar
• Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000;18(1):91–98.
   PubMed Web of Science ®Google Scholar
• Speeckaert R, Van Gele M, Speeckaert MM, et al. The biology of hyperpigmentation syndromes. Pigment Cell Melanoma Res. 2014;27(4):512–524. DOI:10.1111/pcmr.12235
   PubMed Web of Science ®Google Scholar
• Thomas AJ, Erickson CA. The making of a melanocyte: the specification of melanoblasts from the neural crest. Pigment Cell Melanoma Res. 2008;21(6):598–610.
   PubMed Web of Science ®Google Scholar
• Katiyar S, Yadav D. Correlation of oxidative stress with melasma: an overview. Curr Pharm Des. 2022;28(3):225–231.
   PubMed Web of Science ®Google Scholar
• Seçkin HY, Kalkan G, Baş Y, et al. Oxidative stress status in patients with melasma. Cutan Ocul Toxicol. 2014;33(3):212–217. DOI:10.3109/15569527.2013.834496
   PubMed Web of Science ®Google Scholar
• Resnik S. Melasma induced by oral contraceptive drugs. JAMA. 1967;199(9):601–605.
   PubMed Web of Science ®Google Scholar
• Still R, Brennecke S. Melanoma in pregnancy. Obstet Med. 2017;10(3):107–112.
   PubMedGoogle Scholar
• Tyler K. Physiological skin changes during pregnancy. Clin Obstet Gynecol. 2015;58(1):119–124.
   PubMed Web of Science ®Google Scholar
• McNeill H, Jensen PJ. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration. Cell Regul. 1990;1(11):843–852.
   PubMedGoogle Scholar
• Zhu J-W, Y-J N, Tong X-Y, et al. Tranexamic acid inhibits angiogenesis and melanogenesis in vitro by targeting VEGF receptors. Int J Med Sci. 2020;17(7):903–911. DOI:10.7150/ijms.44188
   PubMed Web of Science ®Google Scholar
• Tomita Y, Hariu A, Mizuno C, et al. Inactivation of tyrosinase by Dopa. J Invest Dermatol. 1980;75(5):379–382. DOI:10.1111/1523-1747.ep12523615
   PubMed Web of Science ®Google Scholar
• Manosroi A, Podjanasoonthon K, Manosroi J. Development of novel topical tranexamic acid liposome formulations. Int J Pharm. 2002;235(1–2):61–70. DOI:10.1016/S0378-5173(01)00980-2
   PubMed Web of Science ®Google Scholar
• Raath MI, Weijer R, Nguyen GH, et al. Tranexamic acid-encapsulating thermosensitive liposomes for site-specific pharmaco-laser therapy of port wine stains. J Biomed Nanotechnol. 2016 Aug;12(8):1617–1640.
   PubMed Web of Science ®Google Scholar
• Podjanasoonoth K. Entrapment of tranexamic acid in liposomes. Chiang Mai University. 2000. Available at:https://cmudc.library.cmu.ac.th/frontend/Info/item/dc:97542
   Google Scholar
• Banihashemi M, Zabolinejad N, Jaafari MR, et al. Comparison of therapeutic effects of liposomal tranexamic acid and conventional hydroquinone on melasma. J Cosmet Dermatol. 2015;14(3):174–177. DOI:10.1111/jocd.12152
   PubMed Web of Science ®Google Scholar
• Huang M-H, Huang S-Y, Chen Y-X, et al. Elaboration of charged poly(lactic-co-Glycolic acid) microparticles for effective release of tranexamic acid. Polymers. 2020;12(4):808.
   PubMed Web of Science ®Google Scholar
• Machekposhti S A, Soltani M, Najafizadeh P, et al. Biocompatible polymer microneedle for topical/dermal delivery of tranexamic acid. J Control Release. Internet 2017;261:87–92. DOI:10.1016/j.jconrel.2017.06.016
   PubMed Web of Science ®Google Scholar
• Xing M, Wang X, Zhao L, et al. Novel dissolving microneedles preparation for synergistic melasma therapy: combined effects of tranexamic acid and licorice extract. Int J Pharm. 2021;600:120406.
   PubMedGoogle Scholar
• Rahman M, Alam K, Beg S, et al. Liposomes as topical drug delivery systems: State of the arts. Biomedical Applications of Nanoparticles. William Andrew Publishing; 2019. p. 149–161. DOI:10.1016/B978-0-12-816506-5.00004-8
   Google Scholar
• Yasaswi PS, Shetty K, Yadav KS. Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. J Control Release. 2021;336:549–571.
   PubMed Web of Science ®Google Scholar
• Trichard L, Delgado-Charro MB, Guy RH, et al. Novel beads made of alpha-cyclodextrin and oil for topical delivery of a lipophilic drug. Pharm Res. 2008;25(2):435–440. DOI:10.1007/s11095-007-9395-0
   PubMed Web of Science ®Google Scholar
• Aburahma MH. Insights on novel particulate self-assembled drug delivery beads based on partial inclusion complexes between triglycerides and cyclodextrins. Drug Deliv. 2016;23(7):2205–2219.
   PubMed Web of Science ®Google Scholar
• Bochot A, Trichard L, Le Bas G, et al. α-Cyclodextrin/oil beads: an innovative self-assembling system. Int J Pharm. 2007 Jul 18;339(1–2):121–129. DOI:10.1016/j.ijpharm.2007.02.034
   PubMedGoogle Scholar
• Reddy N, Yang Y. Potential of plant proteins for medical applications. Trends Biotechnol. 2011 Oct 1;29(10):490–498.
   PubMed Web of Science ®Google Scholar
• Sezer AD, Cevher E. Topical drug delivery using chitosan nano- and microparticles. Expert Opin Drug Deliv. 2012;9(9):1129–1146.
   PubMed Web of Science ®Google Scholar
• Gelfuso GM, Gratieri T, Simao PS, et al. Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate. J Microencapsul. 2011;28(7):650–658. DOI:10.3109/02652048.2011.604435
   PubMed Web of Science ®Google Scholar
• Waghule T, Singhvi G, Dubey SK, et al. Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed Pharmacother. Internet 2019;109:1249–1258. doi: 10.1016/j.biopha.2018.10.078
   PubMed Web of Science ®Google Scholar
• Kimbrough-Green CK, Griffiths CEM, Finkel LJ, et al. Topical retinoic acid (Tretinoin) for melasma in black patients: a vehicle-controlled clinical trial. Arch Dermatol. Internet. 1994 Jun 1;130(6):727–733. DOI:10.1001/archderm.1994.01690060057005
   PubMedGoogle Scholar
• Gottschalk RW, Agim NG, Ortonne J. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Dermatology. 2010;64(1):78–83.e2.
   PubMed Web of Science ®Google Scholar
• Xing X, Chen L, Xu Z, et al. The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma. J Cosmet Dermatol. 2020;19(12):3238–3244. DOI:10.1111/jocd.13810
   PubMed Web of Science ®Google Scholar
• Gamea MM, Kamal DA, Donia AA, et al. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma. J DermatolTreat. 2022;33(2):798–804. DOI:10.1080/09546634.2020.1781755
   Google Scholar
• Guangzhou Chenxi Chemical Co ltd. Flexible tranexamic acid liposome capable of whitening skin and removing freckles as well as preparation method and application thereof. China; 2022. [cited 15 Feb 2023]; Available from: https://patents.google.com/patent/CN109481321B/en?q=flexible+tranexamic+acid+liposomes&oq=flexible+tranexamic+acid+liposomes
   Google Scholar
• Hangzhou Shizhen Medical Instrument Co ltd. Novel nano tranexamic acid targeting preparation and preparation method thereof. China; 2021. [cited 15 Feb 2023]; Available from: https://patents.google.com/patent/CN113662932A/en?q=novel+nano+tranexamic+acid&oq=novel+nano+tranexamic+acid
   Google Scholar
• Th128608B - New product formulation development of Tranexamic acid in conjunction with liposomes and base in cream or lotion form or gel for topical pharmaceutical or cosmetic use Available from: tH128608B - New product formulation development of Tranexamic acid in conjunction with liposomes and base in cream or lotion form or gel for topical pharmaceutical or cosmetic use. Google Patents. cited 15 Feb 2023
   Google Scholar
• Cn103565743A - Tranexamic acid skin externally applied nano-preparation, as well as preparation method and use thereof - Google Patents. Available from: cN103565743A - Tranexamic acid skin externally applied nano-preparation, as well as preparation method and use thereof. Google Patents Access cited 15 Feb 2023
   Google Scholar